Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours

RAJAN, N ; ELLIOTT, R ; CLEWES, O ; MACKAY, A ; REIS-FILHO, J. S ; BURN, J ; LANGTRY, J ; SIEBER-BLUM, M ; LORD, C. J ; ASHWORTH, A

Oncogene, 2011-10, Vol.30 (41), p.4243-4260 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível